MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

04 Aug 2023 Evaluate
The June 2023 quarter revenue stood at Rs. 691.13 millions, up 8.71% as compared to Rs. 635.77 millions during the corresponding quarter last year.The Net Profit of the company vaulted to 1424.61% to Rs. 78.06  millions from Rs. 5.12 millions in the previous quarter.Operating profit surged to 114.03 millions from the corresponding previous quarter of 31.23 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 691.13 635.77 8.71 691.13 635.77 8.71 2750.52 3186.67 -13.69
Other Income 38.02 30.07 26.44 38.02 30.07 26.44 76.12 126.40 -39.78
PBIDT 114.03 31.23 265.13 114.03 31.23 265.13 356.96 782.09 -54.36
Interest 2.43 4.98 -51.20 2.43 4.98 -51.20 11.97 15.62 -23.37
PBDT 111.60 26.25 325.14 111.60 26.25 325.14 344.99 766.47 -54.99
Depreciation 19.99 19.58 2.09 19.99 19.58 2.09 78.99 76.73 2.95
PBT 91.61 6.67 1273.46 91.61 6.67 1273.46 266.00 689.74 -61.43
TAX 13.55 1.55 774.19 13.55 1.55 774.19 64.81 167.28 -61.26
Deferred Tax 1.72 -7.20 -123.89 1.72 -7.20 -123.89 -7.29 -4.22 72.75
PAT 78.06 5.12 1424.61 78.06 5.12 1424.61 201.19 522.46 -61.49
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 16.50 4.91 235.88 16.50 4.91 235.88 12.98 24.54 -47.12
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..